conivaptan hydrochloride
087-CL-099
Phase 1 small_molecule completed
Quick answer
conivaptan hydrochloride for Liver Disease is a Phase 1 program (small_molecule) at CUMBERLAND PHARMACEUTICALS INC with 2 ClinicalTrials.gov record(s).
Program details
- Company
- CUMBERLAND PHARMACEUTICALS INC
- Indication
- Liver Disease
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed